Search

Search Constraints

You searched for: Author/Creator Piaggio, Eliane

Search Results

1. A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system. (3rd July 2019)

2. Aberrant fucosylation enables breast cancer clusterin to interact with dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN). (2nd September 2019)

3. ATRT-35. SMARCB1-DEFICIENT TUMORS ACTIVATE BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES AND ARE SUSCEPTIBLE TO CHECKPOINT BLOCKADE AND TLR3 ACTIVATION. Issue 2 (22nd June 2018)

4. ATRT-35. SMARCB1-DEFICIENT TUMORS ACTIVATE BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES AND ARE SUSCEPTIBLE TO CHECKPOINT BLOCKADE AND TLR3 ACTIVATION. Issue 2 (22nd June 2018)

5. Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy. (1st January 2020)

6. Carbon monoxide‐treated dendritic cells decrease β1‐integrin induction on CD8+ T cells and protect from type 1 diabetes. Issue 1 (11th December 2012)

7. CD163+ tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes. Issue 2 (13th February 2020)

8. Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen. (2nd July 2016)

9. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8+ T-cell response. Issue 27 (8th June 2016)